
Sign up to save your podcasts
Or


We asked Dr. Mohamed Genead, Chief Medical Officer, Nanoscope Therapeutics to discuss and review the latest developments in optogenetic gene therapy for retinal degenerations.
By Retina Synthesis4.5
88 ratings
We asked Dr. Mohamed Genead, Chief Medical Officer, Nanoscope Therapeutics to discuss and review the latest developments in optogenetic gene therapy for retinal degenerations.

43 Listeners

18 Listeners

100 Listeners

113,121 Listeners

56,944 Listeners

5 Listeners

9,556 Listeners

11 Listeners

47,718 Listeners

51 Listeners

11 Listeners

470 Listeners

19 Listeners

0 Listeners